Woodline Partners LP

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA

Position in RCKT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,295,574

+$696,055 QoQ

Shares Held

641,222

-1.8% QoQ

Ownership

0.587%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. RCKT ranks #147 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,295,574	641,222	-1.8%	Shares	Sole	2026-05-15
2025-06-30	$1,599,519	652,865	0.0%	Shares	Sole	2025-08-14
2025-03-31	$4,354,609	652,865	+0.1%	Shares	Sole	2025-05-15
2024-12-31	$8,200,931	652,421	+8.5%	Shares	Sole	2025-02-14
2024-09-30	$11,101,633	601,063	+7.0%	Shares	Sole	2024-11-14
2024-06-30	$12,099,127	561,966	+72.1%	Shares	Sole	2024-08-14
2023-03-31	$5,594,743	326,605	+48.3%	Shares	Sole	2023-05-15
2022-12-31	$4,310,351	220,253	+55.1%	Shares	Sole	2023-02-14
2022-03-31	$2,252,294	142,011	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.